Safety and Efficacy of RHH646 for Knee Osteoarthritis
Status:
Not yet recruiting
Trial end date:
2026-01-16
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the articular cartilage-regenerating capacity of
RHH646 in the knee as well as to assess safety and tolerability in participants with knee
osteoarthritis. The treatment duration will be up to 52 weeks. The total study duration for
an individual participant will be up to 62 weeks.